Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5305109c4efec4cbcdd8bc05bdb00399 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
filingDate |
2005-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25170fe4025d1f68c5d40c507d4742a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec0ee27f40f896abe9eed02ce205fb41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d976bfdc97337790fbf2c550e1a16638 |
publicationDate |
2008-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CZ-299493-B6 |
titleOfInvention |
The method of analysis, in particular the determination of the active substance content and its purity |
abstract |
Analysis, in particular the determination of the active substance content and its purity, in a controlled release oral dosage form comprising a polymer or copolymer of an acrylic or methacrylic acid derivative and a pharmaceutically active polar substance selected from the group consisting of tamsulosin hydrochloride and venlafaxine hydrochloride, using standard analytical methods such as HPLC wherein the active ingredient is dissolved in dimethyl sulfoxide or a solvent mixture containing dimethyl sulfoxide. |
priorityDate |
2005-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |